MRK Merck & Company, Inc.
$141.82▲ +0.86%
Healthcare
Other
Volume 9.05M
Avg Volume (10D) 11.38M
Key Metrics & Fundamentals
Market Cap
$349.89B
P/E Ratio
112.6
Div Yield
2.40%
52W Range
82.01 - 156.92
% vs 50 MA
-3.43%
% vs 200 MA
12.41%
RSI-14
44.7
MACD Histogram
-0.3800
Beta (1Y vs SPY)
0.13
Free Cash Flow
$4.48B
Gross Rev
$16.61B
Gross Profit
$12.21B
EBITDA
$1.37B
COGS
$4.40B
Operating Exp
$12.65B
Operating Income
-$433.00M
EBIT
-$433.00M
Pretax Income
-$683.00M
Net Income
-$1.34B
EPS (Diluted)
-0.54
Price & Volume History
Loading chart…
Recent News
Jefferies & Co Adjusts Merck Price Target to $177 From $176
MT Newswires · Oct 28, 2026 7:28 AM ET
Should You Buy Bristol Myers Squibb Stock For Its Cash?
Trefis · Oct 28, 2026 5:25 AM ET
If Eli Lilly Stock Looks Expensive, You Need To Read This
Trefis · Oct 28, 2026 5:25 AM ET
What to Watch This Week: Fed Meeting, More Tech Earnings
The Wall Street Journal · Oct 28, 2026 4:15 AM ET
Merck (MRK) reports Q3: everything you need to know ahead of earnings
StockStory · Oct 28, 2026 1:02 AM ET
Merck (MRK) Gains Fresh Oncology Backing As Valuation Debate Heats Up
Simply Wall St. · Oct 27, 2026 11:11 PM ET
Moderna Stock Plunges. William Blair Issues Fresh Warning After Massive Rally
GuruFocus.com · Oct 27, 2026 2:25 PM ET
4 Blue-Chip Dividend Stocks That Could Turn $200,000 Into Annual Retirement Income
24/7 Wall St. · Oct 27, 2026 2:23 PM ET
Has Regeneron Stock Become A Different Bet?
Trefis · Oct 27, 2026 12:44 PM ET
Scancell cancer vaccine strategy backed by Moderna and Merck trial results
Proactive · Oct 27, 2026 11:30 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See MRK's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.